Bass Berry & Sims PLC | USA | 27 Aug 2019
On July 19, 2019, Myriad Genetics disclosed a $9.1 million settlement agreement to resolve a False Claims Act (FCA) qui tam lawsuit alleging that it…
McKee Voorhees & Sease PLC | USA | 26 Dec 2018
Justice Warren Burger in the seminal case of Diamond v. Chakrabarty found that Congress had intended patentable subject matter to “include anything…
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 11 Dec 2018
As an increased emphasis is placed on protecting our environment and Animal welfare, companies aim to make traditionally animal-derived products from…
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | USA | 7 Sep 2018
Engineered natural products, like lab-grown meat and synthetic milks, are on the cutting edge of food science. Companies in this field often aim to…
Bradley Arant Boult Cummings LLP | USA | 24 Apr 2018
In 2011 the Supreme Court announced that methods of diagnosing disease are ineligible for patenting under its landmark decision, Mayo Collaborative…
FisherBroyles LLP | Australia, USA | 22 Mar 2018
In a recent decision, The Federal Court of Australia held that a method of using gene sequence analysis to identify beneficial traits in cattle was…
Wilmer Cutler Pickering Hale and Dorr LLP | USA | 5 Dec 2017
No provision of the Patent Act has been more frequently litigated over the last several years than 35 U.S.C. 101. After not having decided a 101 case…
Kirkland & Ellis LLP | USA | 13 Jun 2017
In the few years since the Supreme Court turned to the issue of patent eligibility with its decisions in Mayo Collaborative Servs v Prometheus Labs…
GQ Life Sciences | USA | 18 May 2017
Patentable subject matter is defined in the 35 U.S.C. § 101 as: “any new and useful process, machine, manufacture, or composition of matter”, with the…
Knobbe Martens | USA | 19 Mar 2017
Myriad Genetics recently announced clinical results showing that its BRACAnalysis CDx® test was able to identify patients with HER2-negative…